vs
Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and FGI Industries Ltd. (FGI). Click either name above to swap in a different company.
FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $18.6M, roughly 1.6× ENANTA PHARMACEUTICALS INC). FGI Industries Ltd. runs the higher net margin — -8.6% vs -64.1%, a 55.5% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -14.4%). FGI Industries Ltd. produced more free cash flow last quarter ($2.3M vs $-11.8M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs -0.5%).
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
ENTA vs FGI — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $30.5M |
| Net Profit | $-11.9M | $-2.6M |
| Gross Margin | — | 26.7% |
| Operating Margin | -60.5% | -2.2% |
| Net Margin | -64.1% | -8.6% |
| Revenue YoY | 9.8% | -14.4% |
| Net Profit YoY | 46.4% | -553.1% |
| EPS (diluted) | $-0.42 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $30.5M | ||
| Q3 25 | $15.1M | $35.8M | ||
| Q2 25 | $18.3M | $31.0M | ||
| Q1 25 | $14.9M | $33.2M | ||
| Q4 24 | $17.0M | $35.6M | ||
| Q3 24 | $14.6M | $36.1M | ||
| Q2 24 | $18.0M | $29.4M | ||
| Q1 24 | $17.1M | $30.8M |
| Q4 25 | $-11.9M | $-2.6M | ||
| Q3 25 | $-18.7M | $-1.7M | ||
| Q2 25 | $-18.3M | $-1.2M | ||
| Q1 25 | $-22.6M | $-629.1K | ||
| Q4 24 | $-22.3M | $-402.3K | ||
| Q3 24 | $-28.8M | $-550.1K | ||
| Q2 24 | $-22.7M | $163.6K | ||
| Q1 24 | $-31.2M | $-412.2K |
| Q4 25 | — | 26.7% | ||
| Q3 25 | — | 26.5% | ||
| Q2 25 | — | 28.1% | ||
| Q1 25 | — | 26.8% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | — | 25.8% | ||
| Q2 24 | — | 30.5% | ||
| Q1 24 | — | 27.4% |
| Q4 25 | -60.5% | -2.2% | ||
| Q3 25 | -121.6% | 1.0% | ||
| Q2 25 | -103.2% | -2.7% | ||
| Q1 25 | -164.3% | -3.9% | ||
| Q4 24 | -138.8% | -3.5% | ||
| Q3 24 | -204.4% | -0.2% | ||
| Q2 24 | -134.6% | -1.5% | ||
| Q1 24 | -192.1% | -1.0% |
| Q4 25 | -64.1% | -8.6% | ||
| Q3 25 | -123.6% | -4.6% | ||
| Q2 25 | -99.7% | -4.0% | ||
| Q1 25 | -151.7% | -1.9% | ||
| Q4 24 | -131.4% | -1.1% | ||
| Q3 24 | -197.3% | -1.5% | ||
| Q2 24 | -126.1% | 0.6% | ||
| Q1 24 | -182.7% | -1.3% |
| Q4 25 | $-0.42 | $-1.63 | ||
| Q3 25 | $-0.88 | $-0.86 | ||
| Q2 25 | $-0.85 | $-0.64 | ||
| Q1 25 | $-1.06 | $-0.07 | ||
| Q4 24 | $-1.05 | $-0.38 | ||
| Q3 24 | $-1.36 | $-0.29 | ||
| Q2 24 | $-1.07 | $0.08 | ||
| Q1 24 | $-1.47 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $1.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $126.6M | $17.3M |
| Total Assets | $329.5M | $69.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.4M | $1.9M | ||
| Q3 25 | $32.3M | $1.9M | ||
| Q2 25 | $44.8M | $2.5M | ||
| Q1 25 | $60.2M | $1.2M | ||
| Q4 24 | $84.3M | $4.6M | ||
| Q3 24 | $37.2M | $3.0M | ||
| Q2 24 | $35.8M | $1.3M | ||
| Q1 24 | $63.5M | $3.3M |
| Q4 25 | $126.6M | $17.3M | ||
| Q3 25 | $64.7M | $19.7M | ||
| Q2 25 | $79.3M | $21.3M | ||
| Q1 25 | $93.5M | $21.8M | ||
| Q4 24 | $111.8M | $22.3M | ||
| Q3 24 | $128.8M | $23.5M | ||
| Q2 24 | $148.9M | $23.8M | ||
| Q1 24 | $166.1M | $23.9M |
| Q4 25 | $329.5M | $69.5M | ||
| Q3 25 | $280.7M | $73.0M | ||
| Q2 25 | $301.0M | $71.7M | ||
| Q1 25 | $323.0M | $68.5M | ||
| Q4 24 | $348.6M | $75.5M | ||
| Q3 24 | $376.7M | $74.7M | ||
| Q2 24 | $398.8M | $69.9M | ||
| Q1 24 | $413.6M | $68.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $2.3M |
| Free Cash FlowOCF − Capex | $-11.8M | $2.3M |
| FCF MarginFCF / Revenue | -63.6% | 7.5% |
| Capex IntensityCapex / Revenue | 0.8% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-18.5M | $-212.5K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.7M | $2.3M | ||
| Q3 25 | $-6.5M | $-1.9M | ||
| Q2 25 | $17.5M | $7.6M | ||
| Q1 25 | $-13.5M | $-7.4M | ||
| Q4 24 | $-16.8M | $617.4K | ||
| Q3 24 | $-10.4M | $-915.0K | ||
| Q2 24 | $-14.8M | $862.1K | ||
| Q1 24 | $-28.6M | $-8.0M |
| Q4 25 | $-11.8M | $2.3M | ||
| Q3 25 | $-7.9M | $-2.1M | ||
| Q2 25 | $17.4M | $7.4M | ||
| Q1 25 | $-16.0M | $-7.7M | ||
| Q4 24 | $-25.5M | $-214.1K | ||
| Q3 24 | $-19.4M | $-1.1M | ||
| Q2 24 | $-21.3M | $281.5K | ||
| Q1 24 | $-30.3M | $-8.6M |
| Q4 25 | -63.6% | 7.5% | ||
| Q3 25 | -52.5% | -5.9% | ||
| Q2 25 | 94.7% | 23.8% | ||
| Q1 25 | -107.4% | -23.3% | ||
| Q4 24 | -150.6% | -0.6% | ||
| Q3 24 | -132.5% | -3.0% | ||
| Q2 24 | -118.6% | 1.0% | ||
| Q1 24 | -177.5% | -28.0% |
| Q4 25 | 0.8% | 0.2% | ||
| Q3 25 | 9.6% | 0.7% | ||
| Q2 25 | 0.8% | 0.7% | ||
| Q1 25 | 17.0% | 1.1% | ||
| Q4 24 | 51.6% | 2.3% | ||
| Q3 24 | 61.3% | 0.5% | ||
| Q2 24 | 36.4% | 2.0% | ||
| Q1 24 | 9.8% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.27× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENTA
Segment breakdown not available.
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
